Most operating room performance reports are built around a small set of familiar metrics: utilization rate, first case on-time start, turnover time, case volume, and cancellation rate.
These are real metrics and they matter. They're also the metrics that are easiest to pull from scheduling systems, which is exactly why they're the ones that get reported, even when more consequential cost drivers may be sitting in data that nobody is pulling.
The OR is one of the most financially significant units in a hospital. A single minute of operating room time costs between $22 and $133 depending on procedure type and facility, with a peer-reviewed editorial published in the Journal of Clinical Anesthesia reporting an average of $62 per minute when direct labor, overhead, supplies, and equipment are included.
At that rate, cost problems that don't show up on a standard report compound quickly and quietly.
The six cost drivers below require connecting data from scheduling, supply chain, billing, and clinical documentation simultaneously, which is exactly the kind of cross-system view most OR reports were never built to provide, and where the most recoverable OR margin currently sits.
Beyond the Report: 6 Operating Room Cost Drivers You're Not Tracking
1. Preference Card Inflation That Nobody Has Audited in Years
A preference card specifies the supplies, instruments, equipment, and setup preferences a surgeon requires for a specific procedure. In principle it's a precision document. In practice, most preference cards are years old and haven't been checked against what actually gets used.
A November 2025 study published in JAMA Surgery by researchers at UC San Diego analyzed preference cards and procedures across a five-year dataset and found $3.7 million in savings opportunity from unused items alone, including a 31.1% reduction in unused item costs once cards were optimized against actual usage data.
What makes this invisible on a standard OR report is that wasted supplies get absorbed into the general supply cost line without ever being attributed to the specific card, surgeon, or procedure type that generated them.
Connecting intraoperative usage data against pre-case pull lists is the only way to quantify this gap at the case level and it's a connection most OR reporting simply doesn't make.
2. The Downstream Cascade Cost of a Late First Case
First case on-time start rate is a standard metric. What most reports don't capture is the cumulative downstream cost when that first case runs late.
A 10-minute delay at 7:00 AM doesn't cost 10 minutes. It creates a ripple across every subsequent case in that OR: turnover windows compress, surgeons run behind, staffing runs into overtime to cover cases extending into the late afternoon, and scheduled cases get pushed or cancelled.
The financial impact of each of those outcomes flows into a different budget line, none of which get traced back to the original delay.
At $62 per minute, a 15-minute first case delay costs approximately $930 in direct OR cost before that ripple effect across the rest of the day is even calculated.
Tracing delay attribution across the full day, rather than reporting first-case start rates in isolation, is what reveals a cost figure most OR finance teams have never actually seen.
3. Vendor Representative Presence Without Contract Oversight
Medical device and implant vendor representatives are present in operating rooms across the country for procedures involving their products. This is standard industry practice, and in many cases the clinical support they provide is genuine and valued.
The issue isn't that reps are in the room — it's that hospitals rarely have analytics tracking what that presence correlates with. Vendor representatives are, by design, incentivized to support the use of their own company's products, and in procedures with multiple viable device options, their presence in the room is one more variable shaping which option gets used.
This is a well-understood dynamic in hospital supply chain and GPO circles, one of the reasons physician preference items remain notoriously difficult to standardize and one of the reasons implant and device spend is one of the least predictable lines in a surgical budget.
The cost driver here is implant and device spend that exceeds contracted pricing or GPO agreements, because product selection in the room isn't consistently checked against the contract at the point of use. Most hospitals only discover the mismatch after the fact, if at all, when the supply chain reconciles invoices against contract terms — a process that happens periodically rather than case by case.
Business intelligence for healthcare that connects vendor credentialing data, case-level implant usage, and contract pricing identifies where vendor presence is associated with above-contract spend and where it is not.
4. Bill-Only Implant Processing Lag That Disrupts Revenue Capture
Bill-Only implants enter the facility outside the normal procurement process, which means they move through clinical use, charge capture, and billing on separate timelines from standard inventory.
In many hospitals, that process still relies on paper forms, spreadsheets, and email handoffs between clinical staff, supply chain, and finance.
The result (reported consistently in perioperative supply chain literature) is undocumented spend, delayed billing cycles, and charge capture gaps where implants are used but never billed, or billed at the wrong price.
This doesn't show up on a standard OR report because the gap lives between the OR report and the billing system, in a handoff neither system owns. Closing it requires connecting OR case documentation with Bill-Only invoice data and charge capture records in a single audit layer, rather than chasing it case by case.
5. Surgical Supply Expiration Losses Absorbed Into Overhead
OR supply rooms hold inventory against scheduled cases. When cases are cancelled, delayed, or the procedure mix shifts, items on the shelf approach and pass their expiration date.
The cost of expired supplies typically gets absorbed into the facility overhead budget as a general supply expense and is rarely traced back to the scheduling or cancellation pattern that caused it.
The problem tends to come from high turnover of short-shelf-life products driven by case volume variability, not from large stockpiles, which is exactly why it stays invisible on a standard report.
Connecting case scheduling data with inventory expiration tracking and supply ordering patterns is what identifies the specific procedure types, cancellation rates, and lead times generating those losses, before the next cycle of waste accumulates.
6. Case Duration Variance by Surgeon That Never Gets Attributed to Cost
Utilization rate is typically reported at the room level. The surgeon-level pattern actually driving that rate down, and the overtime it generates, rarely shows up in the same report.
A case duration variance analysis broken down by surgeon, procedure type, and time of day, connected to its downstream cost, gives OR directors a tool they usually don't have: the ability to have a data-supported conversation with a surgeon about scheduling patterns before those patterns keep eroding the OR budget.
This kind of cost visibility is the natural complement to utilization rate reporting. If you're currently working on closing the capacity gap in OR scheduling, our piece on how data-driven OR scheduling closes the capacity gap without adding rooms covers the scheduling side of the same problem in detail.
Frequently Asked Questions
How often should surgical preference cards be reviewed and updated?
Most perioperative programs review preference cards annually at minimum, more often for high-volume or high-cost procedures.
The challenge is that usage data and preference card data typically live in separate systems, which is exactly what we connect to make the comparison routine rather than a manual periodic audit.
What is the financial impact of the first case on-time start rate across a full year?
At $62 per minute, a 10-minute first case delay in a single OR, repeated across roughly 250 operating days a year, adds up to more than $150,000 in direct cost alone — before overtime, cascade effects, or multiplying across every room in a multi-room suite.
First case on-time start is a financial metric, not just an efficient one, and it should be reported that way.
Can Bill-Only implant spend be tracked under the same analytics as standard supply spend?
Yes, but it requires deliberate integration work, since Bill-Only items typically sit outside the ERP or materials management system that standard supply spend flows through.
Ascend Analytics connects vendor invoice data, case documentation, and contract pricing into a single reconciliation layer to give a complete per-case implant spend picture.
How does case duration variance analytics differ from standard OR scheduling reports?
Standard scheduling reports show planned versus actual case duration in aggregate.
Ascend Analytics breaks that variance down by surgeon, procedure type, and day of week, then connects it to downstream cost metrics like overtime and case push rates, so the attribution is clear rather than just observed.
Why is surgical supply expiration not tracked on most OR financial reports?
Expiration losses are typically posted to a general overhead account at disposal, rather than traced back to the scheduling or ordering decision that caused them.
Connecting disposal data to upstream case and ordering data is what surfaces the pattern before the next cycle of losses builds up.
Are Your OR Cost Reports Showing You What Is Actually Driving the Loss?
A standard OR report tells you how many cases ran, what the utilization rate was, how turnover compared to target, and how many first cases started on time. It doesn't tell you why margin is still under pressure despite those numbers holding steady, or where the cost is actually going.
Preference card inflation accumulates quietly over years. Cascade delay costs from a single late first case spread across an entire surgical day and land in five different budget lines.
Vendor presence without contract oversight inflates implant spend in ways that only become visible when case-level data is connected to contract pricing. Bill-Only processing gaps let implant revenue slip through the handoff between the OR and billing.
Supply expiration losses get absorbed into overhead without attribution to the scheduling patterns that caused them. And surgeon-level case duration variance keeps generating overtime and pushed cases until someone connects that data to the downstream cost it produces.
Each of these has a data solution; they just don't have a place on a standard OR report, which is why they persist even in well-run perioperative programs.
Ascend Analytics builds the cross-system analytics layer that connects OR scheduling, supply chain, billing, clinical documentation, and vendor data into a single view of perioperative financial performance.
That's where the recoverable margin in most OR environments actually sits.
If your OR performance reports aren't answering the question of where the margin is going, reach out and we'll show you what a connected perioperative analytics program finds in the data your current reports aren't pulling.
